![]() |
The Johnson & Johnson Tylenol Controversies




Abstract
Issuess
The case is structured to achieve the following teaching objectives:
- Ethical issues involved in the overdose controversy and discuss the right approach to resolving the crisis in right, proper and just way
Contents |
Tylenol Deaths |
Background Note |
The Fall and Rise of Tylenol |
The Tylenol Overdose Controversy |
Making the Public Aware of Risks |
Exhibits |
Keywords
Johnson & Johnson,analgesic,overdose,kidney problems,Pain Killers, gastrointestinal ulcers,bleeding ,Joseph Lister,Robert Wood Johnson,TENS,J&J, Tylenol, acetaminophen-based analgesic, OTC drug,leader,1982, Cyanide, six months, Tylenol, medical practitioners, side-effects, bad publicity, millions, dollars, legal settlements,1997, FDA labeling rules